<DOC>
	<DOCNO>NCT02835235</DOCNO>
	<brief_summary>This trial conduct United States America . The aim trial investigate Safety , Tolerability , PK PD Multiple Doses NNC9204-0530 Male Female Subjects overweight obesity</brief_summary>
	<brief_title>A Trial Investigating Safety , Tolerability , PK PD Multiple Doses NNC9204-0530 Male Female Subjects Being Overweight With Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>Male female , age 18 55 year ( inclusive ) time sign informed consent Body mass index 25.0 39.9 kg/m^2 ( inclusive ) screening . Haemoglobin A1c ( HbA1c ) equal 6.5 % Any clinically significant weight change ( equal 5 % selfreported change ) dieting attempt ( e.g . participation organize weight reduction program ) within last 90 day prior screen Any prior obesity surgery currently present gastrointestinal implant . Abnormal ECG ( electrocardiogram ) result include 2nd 3rd degree AVblock , prolongation QRS complex 120 m , QTcF interval 430 m ( male ) 450 m ( female ) , clinically relevant abnormal result , judge investigator A history additional risk factor Torsades de pointes ( e.g. , heart failure , hypokalaemia , family history Long QT Syndrome ) History pancreatitis ( acute chronic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>